Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Anti-Thymocyte Globulin versus Interleukin-2 Receptor Antagonist in Kidney Transplant Recipients with Hepatitis C Virus.

Bae S, Durand CM, Garonzik-Wang JM, Chow EKH, Kucirka LM, DeMarco MAM, Massie AB, Al Ammary F, Coresh J, Segev DL.

Transplantation. 2019 Sep 13. doi: 10.1097/TP.0000000000002959. [Epub ahead of print]

PMID:
31568217
2.

Increased placental T cell trafficking results in adverse neurobehavioral outcomes in offspring exposed to sub-chronic maternal inflammation.

Novak CM, Lee JY, Ozen M, Tsimis ME, Kucirka LM, McLane MW, Xie L, Kelleher M, Xie H, Jia B, Lei J, Burd I.

Brain Behav Immun. 2019 Jan;75:129-136. doi: 10.1016/j.bbi.2018.09.025. Epub 2018 Sep 25.

PMID:
30261304
3.

Changes in practice and perception of hepatitis C and liver transplantation: Results of a national survey.

Shaffer AA, Thomas AG, Bowring MG, Van Pilsum Rasmussen SE, Cash A, Kucirka LM, Alqahtani SA, Gurakar A, Sulkowski MS, Cameron AM, Segev DL, Durand CM.

Transpl Infect Dis. 2018 Dec;20(6):e12982. doi: 10.1111/tid.12982. Epub 2018 Sep 21.

4.

Changes in Utilization and Discard of HCV Antibody-Positive Deceased Donor Kidneys in the Era of Direct-Acting Antiviral Therapy.

Bowring MG, Kucirka LM, Massie AB, Ishaque T, Bae S, Shaffer AA, Garonzik Wang J, Sulkowski M, Desai N, Segev DL, Durand CM.

Transplantation. 2018 Dec;102(12):2088-2095. doi: 10.1097/TP.0000000000002323.

5.

The Drug Overdose Epidemic and Deceased-Donor Transplantation in the United States: A National Registry Study.

Durand CM, Bowring MG, Thomas AG, Kucirka LM, Massie AB, Cameron A, Desai NM, Sulkowski M, Segev DL.

Ann Intern Med. 2018 May 15;168(10):702-711. doi: 10.7326/M17-2451. Epub 2018 Apr 17.

6.

Incidence, Risk Factors, and Treatment of Achilles Tendon Rupture in Patients With End-Stage Renal Disease.

Humbyrd CJ, Bae S, Kucirka LM, Segev DL.

Foot Ankle Int. 2018 Jul;39(7):821-828. doi: 10.1177/1071100718762089. Epub 2018 Mar 27.

7.

Association of Race and Ethnicity With Live Donor Kidney Transplantation in the United States From 1995 to 2014.

Purnell TS, Luo X, Cooper LA, Massie AB, Kucirka LM, Henderson ML, Gordon EJ, Crews DC, Boulware LE, Segev DL.

JAMA. 2018 Jan 2;319(1):49-61. doi: 10.1001/jama.2017.19152.

8.

Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys.

Bowring MG, Holscher CM, Zhou S, Massie AB, Garonzik-Wang J, Kucirka LM, Gentry SE, Segev DL.

Am J Transplant. 2018 Mar;18(3):617-624. doi: 10.1111/ajt.14577. Epub 2017 Dec 5.

9.

Pregnant trauma victims experience nearly 2-fold higher mortality compared to their nonpregnant counterparts.

Deshpande NA, Kucirka LM, Smith RN, Oxford CM.

Am J Obstet Gynecol. 2017 Nov;217(5):590.e1-590.e9. doi: 10.1016/j.ajog.2017.08.004. Epub 2017 Aug 24.

PMID:
28844826
10.

Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney Donors.

Muzaale AD, Althoff KN, Sperati CJ, Abraham AG, Kucirka LM, Massie AB, Kitahata MM, Horberg MA, Justice AC, Fischer MJ, Silverberg MJ, Butt AA, Boswell SL, Rachlis AR, Mayor AM, Gill MJ, Eron JJ, Napravnik S, Drozd DR, Martin JN, Bosch RJ, Durand CM, Locke JE, Moore RD, Lucas GM, Segev DL.

Am J Transplant. 2017 Jul;17(7):1823-1832. doi: 10.1111/ajt.14235. Epub 2017 May 12.

11.

Mortality and Graft Loss Attributable to Readmission After Kidney Transplantation: Immediate and Long-term Risk.

King EA, Bowring MG, Massie AB, Kucirka LM, McAdams-DeMarco MA, Al-Ammary F, Desai NM, Segev DL.

Transplantation. 2017 Oct;101(10):2520-2526. doi: 10.1097/TP.0000000000001609.

12.

Times to key events in Zika virus infection and implications for blood donation: a systematic review.

Lessler J, Ott CT, Carcelen AC, Konikoff JM, Williamson J, Bi Q, Kucirka LM, Cummings DA, Reich NG, Chaisson LH.

Bull World Health Organ. 2016 Nov 1;94(11):841-849. Review.

13.

Frailty, Length of Stay, and Mortality in Kidney Transplant Recipients: A National Registry and Prospective Cohort Study.

McAdams-DeMarco MA, King EA, Luo X, Haugen C, DiBrito S, Shaffer A, Kucirka LM, Desai NM, Dagher NN, Lonze BE, Montgomery RA, Walston J, Segev DL.

Ann Surg. 2017 Dec;266(6):1084-1090. doi: 10.1097/SLA.0000000000002025.

14.

Changes in Utilization and Discard of Hepatitis C-Infected Donor Livers in the Recent Era.

Bowring MG, Kucirka LM, Massie AB, Luo X, Cameron A, Sulkowski M, Rakestraw K, Gurakar A, Kuo I, Segev DL, Durand CM.

Am J Transplant. 2017 Feb;17(2):519-527. doi: 10.1111/ajt.13976. Epub 2016 Aug 24.

15.

Assessing the global threat from Zika virus.

Lessler J, Chaisson LH, Kucirka LM, Bi Q, Grantz K, Salje H, Carcelen AC, Ott CT, Sheffield JS, Ferguson NM, Cummings DA, Metcalf CJ, Rodriguez-Barraquer I.

Science. 2016 Aug 12;353(6300):aaf8160. doi: 10.1126/science.aaf8160. Epub 2016 Jul 14. Review.

16.

Induction Immunosuppression and Clinical Outcomes in Kidney Transplant Recipients Infected With Human Immunodeficiency Virus.

Kucirka LM, Durand CM, Bae S, Avery RK, Locke JE, Orandi BJ, McAdams-DeMarco M, Grams ME, Segev DL.

Am J Transplant. 2016 Aug;16(8):2368-76. doi: 10.1111/ajt.13840. Epub 2016 May 25.

17.

Reduced Racial Disparity in Kidney Transplant Outcomes in the United States from 1990 to 2012.

Purnell TS, Luo X, Kucirka LM, Cooper LA, Crews DC, Massie AB, Boulware LE, Segev DL.

J Am Soc Nephrol. 2016 Aug;27(8):2511-8. doi: 10.1681/ASN.2015030293. Epub 2016 Feb 4.

18.

Early Hospital Readmission After Simultaneous Pancreas-Kidney Transplantation: Patient and Center-Level Factors.

King EA, Kucirka LM, McAdams-DeMarco MA, Massie AB, Al Ammary F, Ahmed R, Grams ME, Segev DL.

Am J Transplant. 2016 Feb;16(2):541-9. doi: 10.1111/ajt.13485. Epub 2015 Oct 16.

19.

Outcomes of Live Kidney Donors Who Develop End-Stage Renal Disease.

Muzaale AD, Massie AB, Kucirka LM, Luo X, Kumar K, Brown RS, Anjum S, Montgomery RA, Lentine KL, Segev DL.

Transplantation. 2016 Jun;100(6):1306-12. doi: 10.1097/TP.0000000000000920.

20.

The Other Half of Informed Consent: Transplant Education Practices in Dialysis Centers.

Kucirka LM, Segev DL.

Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1507-9. doi: 10.2215/CJN.08280815. Epub 2015 Aug 20. No abstract available.

21.

Improving Access to Kidney Transplantation: Referral Is Not Enough.

Kucirka LM, Purnell TS, Segev DL.

JAMA. 2015 Aug 11;314(6):565-7. doi: 10.1001/jama.2015.8932. No abstract available.

22.

Landscape of Deceased Donors Labeled Increased Risk for Disease Transmission Under New Guidelines.

Kucirka LM, Bowring MG, Massie AB, Luo X, Nicholas LH, Segev DL.

Am J Transplant. 2015 Dec;15(12):3215-23. doi: 10.1111/ajt.13356. Epub 2015 May 27.

23.

Big data in organ transplantation: registries and administrative claims.

Massie AB, Kucirka LM, Segev DL.

Am J Transplant. 2014 Aug;14(8):1723-30. Review. Erratum in: Am J Transplant. 2014 Nov;14(11):2673. Kuricka, L M [corrected to Kucirka, L M]. Am J Transplant. 2014 Nov;14 (11):2673.

24.

Assessment of resident and fellow knowledge of the organ donor referral process.

Gupta N, Garonzik-Wang JM, Passarella RJ, Salter ML, Kucirka LM, Orandi BJ, Law AH, Segev DL.

Clin Transplant. 2014 Apr;28(4):443-449. doi: 10.1111/ctr.12338. Epub 2014 Mar 27.

25.

Identifying appropriate recipients for CDC infectious risk donor kidneys.

Chow EK, Massie AB, Muzaale AD, Singer AL, Kucirka LM, Montgomery RA, Lehmann HP, Segev DL.

Am J Transplant. 2013 May;13(5):1227-34. doi: 10.1111/ajt.12206.

26.

Recipient age and time spent hospitalized in the year before and after kidney transplantation.

Grams ME, McAdams Demarco MA, Kucirka LM, Segev DL.

Transplantation. 2012 Oct 15;94(7):750-6. doi: 10.1097/TP.0b013e31826205b9.

27.

Disparities in provision of transplant education by profit status of the dialysis center.

Balhara KS, Kucirka LM, Jaar BG, Segev DL.

Am J Transplant. 2012 Nov;12(11):3104-10. doi: 10.1111/j.1600-6143.2012.04207.x. Epub 2012 Aug 6.

28.

Vascular disease, ESRD, and death: interpreting competing risk analyses.

Grams ME, Coresh J, Segev DL, Kucirka LM, Tighiouart H, Sarnak MJ.

Clin J Am Soc Nephrol. 2012 Oct;7(10):1606-14. doi: 10.2215/CJN.03460412. Epub 2012 Aug 2.

29.

Impact of donor hepatitis C virus infection status on death and need for liver transplant in hepatitis C virus-positive kidney transplant recipients.

Kucirka LM, Peters TG, Segev DL.

Am J Kidney Dis. 2012 Jul;60(1):112-20. doi: 10.1053/j.ajkd.2012.03.015. Epub 2012 May 4.

PMID:
22560841
30.

Live donor champion: finding live kidney donors by separating the advocate from the patient.

Garonzik-Wang JM, Berger JC, Ros RL, Kucirka LM, Deshpande NA, Boyarsky BJ, Montgomery RA, Hall EC, James NT, Segev DL.

Transplantation. 2012 Jun 15;93(11):1147-50. doi: 10.1097/TP.0b013e31824e75a5.

31.

Frailty and delayed graft function in kidney transplant recipients.

Garonzik-Wang JM, Govindan P, Grinnan JW, Liu M, Ali HM, Chakraborty A, Jain V, Ros RL, James NT, Kucirka LM, Hall EC, Berger JC, Montgomery RA, Desai NM, Dagher NN, Sonnenday CJ, Englesbe MJ, Makary MA, Walston JD, Segev DL.

Arch Surg. 2012 Feb;147(2):190-3. doi: 10.1001/archsurg.2011.1229.

PMID:
22351919
32.

Pregnancy outcomes of liver transplant recipients: a systematic review and meta-analysis.

Deshpande NA, James NT, Kucirka LM, Boyarsky BJ, Garonzik-Wang JM, Cameron AM, Singer AL, Dagher NN, Segev DL.

Liver Transpl. 2012 Jun;18(6):621-9. doi: 10.1002/lt.23416. Review.

33.

Candidacy for kidney transplantation of older adults.

Grams ME, Kucirka LM, Hanrahan CF, Montgomery RA, Massie AB, Segev DL.

J Am Geriatr Soc. 2012 Jan;60(1):1-7. doi: 10.1111/j.1532-5415.2011.03652.x.

34.

Disparities in provision of transplant information affect access to kidney transplantation.

Kucirka LM, Grams ME, Balhara KS, Jaar BG, Segev DL.

Am J Transplant. 2012 Feb;12(2):351-7. doi: 10.1111/j.1600-6143.2011.03865.x. Epub 2011 Dec 7.

35.

Outcomes of renal transplants from Centers for Disease Control and Prevention high-risk donors with prospective recipient viral testing: a single-center experience.

Lonze BE, Dagher NN, Liu M, Kucirka LM, Simpkins CE, Locke JE, Desai NM, Cameron AM, Montgomery RA, Segev DL, Singer AL.

Arch Surg. 2011 Nov;146(11):1261-6. doi: 10.1001/archsurg.2011.267.

PMID:
22106317
36.

Association of race and age with survival among patients undergoing dialysis.

Kucirka LM, Grams ME, Lessler J, Hall EC, James N, Massie AB, Montgomery RA, Segev DL.

JAMA. 2011 Aug 10;306(6):620-6. doi: 10.1001/jama.2011.1127.

37.

Pregnancy outcomes in kidney transplant recipients: a systematic review and meta-analysis.

Deshpande NA, James NT, Kucirka LM, Boyarsky BJ, Garonzik-Wang JM, Montgomery RA, Segev DL.

Am J Transplant. 2011 Nov;11(11):2388-404. doi: 10.1111/j.1600-6143.2011.03656.x. Epub 2011 Jul 27. Review.

38.

Desensitization in HLA-incompatible kidney recipients and survival.

Montgomery RA, Lonze BE, King KE, Kraus ES, Kucirka LM, Locke JE, Warren DS, Simpkins CE, Dagher NN, Singer AL, Zachary AA, Segev DL.

N Engl J Med. 2011 Jul 28;365(4):318-26. doi: 10.1056/NEJMoa1012376.

39.

Incompatible live-donor kidney transplantation in the United States: results of a national survey.

Garonzik Wang JM, Montgomery RA, Kucirka LM, Berger JC, Warren DS, Segev DL.

Clin J Am Soc Nephrol. 2011 Aug;6(8):2041-6. doi: 10.2215/CJN.02940311. Epub 2011 Jul 22.

40.

Patient attitudes toward CDC high infectious risk donor kidney transplantation: inferences from focus groups.

Ros RL, Kucirka LM, Govindan P, Sarathy H, Montgomery RA, Segev DL.

Clin Transplant. 2012 Mar-Apr;26(2):247-53. doi: 10.1111/j.1399-0012.2011.01469.x. Epub 2011 May 9.

PMID:
21554396
41.

High infectious risk donors: what are the risks and when are they too high?

Kucirka LM, Singer AL, Segev DL.

Curr Opin Organ Transplant. 2011 Apr;16(2):256-61. doi: 10.1097/MOT.0b013e3283449dd3. Review.

PMID:
21415830
42.

Risk of window period hepatitis-C infection in high infectious risk donors: systematic review and meta-analysis.

Kucirka LM, Sarathy H, Govindan P, Wolf JH, Ellison TA, Hart LJ, Montgomery RA, Ros RL, Segev DL.

Am J Transplant. 2011 Jun;11(6):1188-200. doi: 10.1111/j.1600-6143.2011.03460.x. Epub 2011 Mar 14. Review.

43.

Risk of window period HIV infection in high infectious risk donors: systematic review and meta-analysis.

Kucirka LM, Sarathy H, Govindan P, Wolf JH, Ellison TA, Hart LJ, Montgomery RA, Ros RL, Segev DL.

Am J Transplant. 2011 Jun;11(6):1176-87. doi: 10.1111/j.1600-6143.2010.03329.x. Epub 2011 Mar 2. Review.

44.

Provider response to a rare but highly publicized transmission of HIV through solid organ transplantation.

Kucirka LM, Ros RL, Subramanian AK, Montgomery RA, Segev DL.

Arch Surg. 2011 Jan;146(1):41-5. doi: 10.1001/archsurg.2010.303.

PMID:
21242444
45.

Survey of current practice related to grading of rejection in cardiac transplant recipients in North America.

Maleszewski JJ, Kucirka LM, Segev DL, Halushka MK.

Cardiovasc Pathol. 2011 Sep-Oct;20(5):261-5. doi: 10.1016/j.carpath.2010.07.003. Epub 2010 Sep 6.

PMID:
20822924
46.

Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users.

Kucirka LM, Farzadegan H, Feld JJ, Mehta SH, Winters M, Glenn JS, Kirk GD, Segev DL, Nelson KE, Marks M, Heller T, Golub ET.

J Infect Dis. 2010 Sep 15;202(6):845-52. doi: 10.1086/655808.

47.

Survey of North American pathologist practices regarding antibody-mediated rejection in cardiac transplant biopsies.

Kucirka LM, Maleszewski JJ, Segev DL, Halushka MK.

Cardiovasc Pathol. 2011 May-Jun;20(3):132-8. doi: 10.1016/j.carpath.2010.03.008. Epub 2010 Apr 24.

PMID:
20418115
48.

Underutilization of hepatitis C-positive kidneys for hepatitis C-positive recipients.

Kucirka LM, Singer AL, Ros RL, Montgomery RA, Dagher NN, Segev DL.

Am J Transplant. 2010 May;10(5):1238-46. doi: 10.1111/j.1600-6143.2010.03091.x. Epub 2010 Mar 26.

49.

Impact of Medicare coverage on disparities in access to simultaneous pancreas and kidney transplantation.

Melancon JK, Kucirka LM, Boulware LE, Powe NR, Locke JE, Montgomery RA, Segev DL.

Am J Transplant. 2009 Dec;9(12):2785-91. doi: 10.1111/j.1600-6143.2009.02845.x. Epub 2009 Oct 21.

50.

Provider utilization of high-risk donor organs and nucleic acid testing: results of two national surveys.

Kucirka LM, Namuyinga R, Hanrahan C, Montgomery RA, Segev DL.

Am J Transplant. 2009 May;9(5):1197-204. doi: 10.1111/j.1600-6143.2009.02593.x.

Supplemental Content

Loading ...
Support Center